Voices
Federico Nichetti
Federico Nichetti/LinkedIn

Federico Nichetti: Diabetes Mellitus and Treatment Efficacy in Advanced Pancreatic Cancer

Federico Nichetti, Medical Oncologist at Veneto Institute of Oncology, shared a post on X about a recent article he and his colleagues co-authored, adding:

“Just out in ESMO Gastrointestinal Oncology: our PANCAKE study.

Diabetic patients with PDAC longer OS with GemNabP, not FOLFIRINOX.

This work is a testament to a growing community of young researchers dedicated to PDAC with rigorous science.”

Title: Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE study

Authors: P. Andena, G. Tine, F. Nichetti, A. Pretta, L. Bartalini, S. Ljevar, A. Michelotti, L. Salvatore, M. Prisciandaro, A. Franza, G. Grelli, P. Ziranu, M. Bensi, V. Mazzaferro, J. Coppa, C. Sciortino, G. Zapelloni, C. Pircher, S.K. Garattini, C. Vivaldi, G. Tortora, M. Scartozzi, F. de Braud, F. Pietrantonio, R. Miceli, M. Niger

Read the Full Article on ESMO Gastrointestinal Oncology

Federico Nichetti: Diabetes Mellitus and Treatment Efficacy in Advanced Pancreatic Cancer

More posts featuring Federico Nichetti.

A. Franza A. Michelotti A. Pretta C. Pircher C. Sciortino C. Vivaldi cancer Diabetes Mellitus F. de Braud F. Nichetti F. Pietrantonio Federico Nichetti G. Grelli G. Tine G. Tortora G. Zapelloni J. Coppa L. Bartalini L. Salvatore M. Bensi M. Niger M. Prisciandaro M. Scartozzi OncoDaily Oncology P. Andena P. Ziranu Pancreatic Cancer PDAC R. Miceli S. Ljevar S.K. Garattini V. Mazzaferro